Hypertension

deliVERy of optimal blood pressure coNtrol in afrICA (VERONICA)-Nigeria study: Rationale and design of a randomized clinical trial

Am Heart JPublished Randomised controlled trial

Study context

Population
Black African adults with uncontrolled hypertension, untreated or on monotherapy, Nigeriaplanned
Participants
300 adults
Planned comparison
Triple pill-based treatment protocol vs Nigeria hypertension treatment protocol (standard care)
Primary endpoint
Change in home mean SBP from baseline
Follow-up
Month 6
Methodological detailsrationale and design, parallel-group, open-label, 1:1 randomisation, noncomparative 12-month extension, Economic and process evaluations planned, Key secondary outcome: % with clinic blood pressure (BP) <140/90 mmHg at month 6, Primary safety outcome: discontinuation due to adverse events to month 6
  • Rationale and design
  • Parallel-group
  • Open-label
  • 1:1 randomisation
  • Noncomparative 12-month extension
  • Economic and process evaluations planned
  • Key secondary outcome: % with clinic BP <140/90 mmHg at month 6
  • Primary safety outcome: discontinuation due to adverse events to month 6

No results yet. This paper sets out the design of a trial; its results are to come.

Original publication

deliVERy of optimal blood pressure coNtrol in afrICA (VERONICA)-Nigeria study: Rationale and design of a randomized clinical trial. Am Heart J. Published 31 July 2024. doi:10.1016/j.ahj.2024.07.006

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.